are glp 1 drugs dangerous GLP-1 Safety Check Obesity drugs: huge study identifies

Onceweekly albiglutide versus oncedaily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, openlabel, multicentre, noninferiority phase 3 study

Greco EV, Russo G, Giandalia A, Viazzi F, Pontremoli R, De Cosmo S

Earlier studies demonstrated that the incretin effect of GIP was severely impaired in patients with uncontrolled T2DM (57)

Recuperato da: Da Porto A, Casarsa V, Colussi G, Catena C, Cavarape A, Sechi L

These actions go beyond glycemic control, positioning them as potential therapeutic agents for diseases in which inflammation plays a central pathogenic role (Drucker 2018)